EPS for Tabula Rasa HealthCare, Inc. (TRHC) Expected At $-0.07

April 22, 2018 - By Kurt Siggers

Analysts expect Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) to report $-0.07 EPS on May, 7.They anticipate $0.04 EPS change or 36.36 % from last quarter’s $-0.11 EPS. After having $0.06 EPS previously, Tabula Rasa HealthCare, Inc.’s analysts see -216.67 % EPS growth. The stock decreased 1.70% or $0.71 during the last trading session, reaching $40.99. About 135,291 shares traded. Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) has risen 198.94% since April 22, 2017 and is uptrending. It has outperformed by 187.39% the S&P500.

Tabula Rasa HealthCare, Inc. provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to enhance patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. The company has market cap of $820.35 million. The Company’s cloud software applications include EireneRx, which is used by at-risk healthcare organizations to access its patients' medication-related information; MedWise Advisor that allows for components of EireneRx to be used independently and by a broader healthcare audience; and NiaRx, an educational software platform used in the pharmacy educational community. It has a 53.93 P/E ratio. The firm offers its technology-enabled services and products for medication risk management and risk adjustment.

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.